A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients ...

The TNF-alpha inhibitor is indicated to treat children weighing at least 15 kg living with moderately to severely active ...

Fatty fish, lean protein, soluble fiber and softened foods may support gut health in people with ulcerative colitis. Ulcerative colitis requires a personalized approach—there’s no one-size-fits-all ...

The FDA has approved golimumab for the treatment of children with moderately to severely active ulcerative colitis who weigh ...

A 29-year-old man undergoes a total proctocolectomy with end-to-end ileostomy after 2 years of surveillance for ulcerative colitis.

The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis. With ...

Increased uric acid levels in the body is medically known as hyperuricemia, and can often go unnoticed in the early stages. However, when levels remain elevated for longer durations, the body may ...

We’ve all experienced common issues like headaches, vision changes, nausea, stomach pain, and mouth sores. These don’t tend to cause us much worry because they’re usually symptoms of benign issues ...

One in 36 children in the United States has autism, according to the Department of Health and Human Services (HHS) — but many don’t learn they’re on the spectrum until adulthood. Those who grow up ...

The FDA approved a subcutaneous (SC) induction regimen of guselkumab (Tremfya, Johnson & Johnson) for adults with moderately to severely active ulcerative colitis (UC). Guselkumab is the first and ...

CAR T-cell therapy was first developed as a lymphoma treatment but has recently been applied to autoimmune diseases, primarily lupus, systemic sclerosis, and myositis. Up to this point, ulcerative ...